Immediate Impact
51 standout
Citing Papers
Smart hydrogel: A new platform for cancer therapy
2025 Standout
From geroscience to precision geromedicine: Understanding and managing aging
2025 Standout
Works of Douglas J. Harrison being referenced
Phase 1 trial of seclidemstat (SP-2577) in patients with relapsed/refractory Ewing sarcoma.
2021
ABBV-085, Antibody–Drug Conjugate Targeting LRRC15, Is Effective in Osteosarcoma: A Report by the Pediatric Preclinical Testing Consortium
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Douglas J. Harrison | 414 | 236 | 430 | 288 | 50 | 1.0k | |
| Lu Xie | 599 | 413 | 416 | 262 | 55 | 1.1k | |
| Michiro Susa | 349 | 411 | 515 | 281 | 62 | 1.2k | |
| Chunmeng Wang | 276 | 240 | 504 | 278 | 72 | 999 | |
| Stéphane Tercier | 409 | 345 | 520 | 241 | 40 | 1.2k | |
| Giacomo Miserocchi | 330 | 486 | 271 | 169 | 61 | 985 | |
| Désirée Tampe | 316 | 272 | 599 | 193 | 46 | 1.4k | |
| Qiang Li | 387 | 251 | 323 | 150 | 45 | 956 | |
| J Lawry | 258 | 462 | 481 | 237 | 45 | 1.4k | |
| Wangjun Yan | 179 | 195 | 554 | 459 | 42 | 1.2k | |
| Li Teng | 236 | 214 | 415 | 143 | 83 | 1.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...